- ANH activities sold to CVC Capital Partners, reclassified as Discontinued Operations.
- Full-year 2025 results to be reported on February 12, 2026.
- Bovaer moved from ANH to Taste, Texture & Health.
- Nutrition Improvement activities to transfer to Group Sustainability in Q1 2026.
Divestment and Reclassification
dsm-firmenich has announced the divestment of its Animal Nutrition & Health (ANH) activities to CVC Capital Partners. As a result, these assets and liabilities are now classified as Assets Held for Sale, and their financial results are reclassified to Discontinued Operations.
Financial Reporting Adjustments
The company has restated its financial results to reflect Continuing Operations, ensuring a consistent view of ongoing performance. Full-year 2025 results will be reported on February 12, 2026, under this new classification. Comparative figures for recent quarters and full-year 2024 are provided for key metrics like Net Sales and Adjusted EBITDA.
Structural Changes
Several structural adjustments are made in the restated numbers for 2024 and 2025. Perfumery & Beauty is restated for Aroma Ingredients and Pentapharm, while Taste, Texture & Health now includes Bovaer, a methane-reducing feed ingredient. Health, Nutrition & Care is adjusted for Marine Lipids and certain vitamin sales.
Future Reporting Plans
Further comparative details will be provided in the full-year 2025 report. In 2026, Nutrition Improvement activities will transfer from Health, Nutrition & Care to Group Sustainability, reported under Corporate Activities from Q1 2026. These activities generate approximately €20 million in quarterly net sales and operate around break-even at the Adjusted EBITDA level.
